Tatalaksana Dislipidemia Terkait Penyakit Kardiovaskular Aterosklerosis (ASCVD): Fokus pada Penurunan LDL-c
DOI:
https://doi.org/10.55175/cdk.v48i10.136Kata Kunci:
Aterosklerosis, dislipidemia, penyakit kardiovaskular aterosklerosisAbstrak
Dislipidemia mengacu pada peningkatan kadar lipid darah dan merupakan prekursor utama penyakit terkait lipid seperti aterosklerosis, penyakit arteri koroner, dan terlibat dalam sindrom kematian mendadak. Penyakit Kardiovaskular Aterosklerosis (ASCVD- atherosclerotic cardiovascular disease) dan manifestasi klinisnya seperti infark miokard dan stroke iskemik merupakan penyebab utama morbiditas dan mortalitas di dunia. Dislipidemia dapat dikendalikan secara farmakologis dan paling penting melalui perubahan gaya hidup terutama diet. Penurunan kadar kolesterol lipoprotein densitas rendah (LDL-c) menghasilkan penurunan risiko ASCVD.
Dyslipidemia is a medical condition characterized by elevation of any or all blood lipid components; dyslipidemia is the major precursor of lipidrelated ailment such as atheros clerosis, coronary artery disease, and also involved in sudden death syndrome. Atherosclerotic cardiovascular disease (ASCVD) and its clinical manifestations,such as myocardial infarction and ischaemic stroke, are the leading cause of morbidity and mortality throughout the world. Dyslipidemia can be controlled pharmacologically and most importantly change in lifestyle especially diet. Reduced low-density lipoprotein cholesterol (LDL-c) resulted in subsequent risk reduction.
Unduhan
Referensi
Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 2018;276:98-108.
Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams textbook of endocrinology. Elsevier Health Sciences; 2015.
Oktaviano YH, Subagjo A, Lefi A, Putra RM, editors. Transforming global cardiovascular health through collaboration facing future challenge and inovations: Proceeding of 11th Surabaya Cardiology Update in Conjunction with Continuing Medical Education XXII; 2020 December 18-20; Surabaya, Indonesia: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia; 2020.
Anagnostis P, Paschou SA, Goulis DG, Athyros VG, Karagiannis A. Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit? Maturitas.2018;108:45-52.
Aman A, Soewondo P, Soelistijo S. Pedoman pengelolaan dislipidemia di Indonesia 2019. PB PERKENI; 2019.
Cabezas MC, Burggraaf B, Klop B. Dyslipidemias in clinical practice. Clinica Chimica Acta. 2018;487:117-25.
Verma N. Introduction to hyperlipidemia and its treatment: A review. Int J Curr Pharm Res. 2016;9(1):6-14.
Onwe P, Folawiyo M, Anyigor-Ogah C, Umahi G, Okorocha A, Afoke A. Hyperlipidemia: Etiology and possible control. Dent Med Sci. 2015;14(10):93-100.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal 2020;41(1):111-88.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines (vol 139,pg e1082, 2019). Circulation 2019;139(25):1182-6.
Wengrofsky P, Lee J, Makaryus AN. Dyslipidemia and its role in the pathogenesis of atherosclerotic cardiovascular disease: Implications for evaluation and targets for treatment of dyslipidemia based on recent guidelines. Dyslipidemia: Intech Open; 2019.
Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocrine Practice 2017;23:1-87.
Rader DJ. New therapeutic approaches to the treatment of dyslipidemia. Cell Metabolism. 2016;23(3):405-12.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2021 Cermin Dunia Kedokteran
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.